Competitive Clinical Research Grant
Supports independent clinical research aligned with Lilly’s scientific priorities, offering funding or study drug via competitive RFPs for investigator-initiated studies.
Funder: Eli Lilly and Company
Due Dates: Rolling (RFP-based deadlines)
Funding Amounts: Funding levels and/or study drug support vary by RFP; no fixed maximum, project budgets are reviewed per proposal.
Summary: Supports independent investigator-initiated clinical research aligned with Lilly’s scientific priorities, offering funding and/or study drug through competitive RFPs.
Description
Lilly's Competitive Clinical Research Grant program is designed to support external clinical studies that are initiated, designed, and sponsored by independent researchers or institutions. The program operates through publicly posted Requests for Proposals (RFPs) that outline specific therapeutic areas or research questions of interest to Lilly. Selected projects may receive financial support and/or provision of study drug, with the final selection determined by global committees of Lilly medical and scientific staff, and sometimes external experts.
Approved studies are fully managed and sponsored by the grantee, who is responsible for all aspects of study design, conduct, and regulatory compliance. This grant mechanism is intended to foster independent research that advances scientific knowledge and addresses key questions relevant to Lilly’s therapeutic interests.
